Linda C.
Linda C. Anderson, Bronson, TX US
Patent application number | Description | Published |
---|---|---|
20130261510 | RECLINABLE THERAPEUTIC MASSAGE CHAIR - A therapeutic massage chair is reclinable between a horizontal and inclined position. The chair includes an upper back support member and a lower support member that is axially movable along a support frame and is also rotatable about an axis which is perpendicular to the plane of the upper back support member. Electric linear actuators are provided to both axially move and oscillate the lower body support member. | 10-03-2013 |
20150290069 | Reclinable Therapeutic Massage Chair - A therapeutic massage chair is reclinable between a horizontal and inclined position. The chair includes an upper back support member and a lower support member that is axially movable along a support frame and is also rotatable about an axis which is perpendicular to the plane of the upper back support member. Electric linear actuators are provided to both axially move and oscillate the lower body support member. | 10-15-2015 |
Linda C. Blomstedt, Bristol, NH US
Patent application number | Description | Published |
---|---|---|
20100198888 | SYSTEM FOR MANAGING DISTRIBUTED ASSETS AND MEDADATA - A system for managing distributed digital assets and related metadata in a network, including several interconnected nodes, each of the interconnected nodes providing accessibility to the distributed digital assets via user controlled stores and caching subsystems such that the management of the assets and related metadata is based on predetermined criteria. Each node includes a caching subsystem, a metadata store, a controller, a user-controlled asset component, and a networking subsystem for communication between each of the nodes. The interconnected nodes provide support for platform operation of client applications. | 08-05-2010 |
Linda C. Burkly, Monument Beach, MA US
Patent application number | Description | Published |
---|---|---|
20150291688 | Methods For Treating Tweak-Related Conditions - The present invention provides methods and agents for the treatment of TWEAK-related conditions, including cardiac, liver, kidney, lung, adipose, skeletal, muscle, neuronal, bone and cartilage conditions. The invention also provides methods for identifying TWEAK agonists or antagonists for the treatment of TWEAK-related conditions. Additionally, the invention provides transgenic animals that express an exogenous DNA encoding a TWEAK polypeptide, or fragments, analogs, or muteins thereof, and methods for using such animals to identify TWEAK agonists or antagonists. The invention further provides methods for diagnosing a disease based on TWEAK expression. The invention also provides methods for affecting cellular differentiation of progenitor cells using TWEAK polypeptides, agonists, or antagonists. | 10-15-2015 |
Linda C. Burkly, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20150017155 | AGLYCOSYL ANTI-CD154 (CD40 LIGAND) ANTIBODIES AND USES THEREOF - The invention relates to aglycosyl anti-CD154 antibodies or antibody derivatives, characterized by a modification at the conserved N-linked site in the C | 01-15-2015 |
Linda C. Foltis, Nutley, NJ US
Patent application number | Description | Published |
---|---|---|
20100297201 | Use of Polyelectrolyte Complexes in Antiperspirant Technology - Polyelectrolyte complexes between cationic polymers and anionic polymers are used in antiperspirant compositions containing an active antiperspirant ingredient. | 11-25-2010 |
20110219552 | Method of Protecting Dyed Hair Color from Fading or Wash-Out - A method of protecting dyed hair color from fading or wash-out during exposure to air and/or shampooing is described. In accordance with one aspect the method includes treating dyed hair with a composition containing (i) a hydrophobically modified quaternary polymer, (ii) a hydrophobically modified polymer plus a cationic surfactant, (iii) a polymer containing diethylaminopropyl methacrylamide (DMAPMA), dimethylaminoethyl methacrylamide (DMAEMA) or diethylaminoethyl methacrylamide (DEAEMA) or (iv) a combination thereof. | 09-15-2011 |
20130202544 | THICKENED COMPOSITONS OF HIGH PH - Provided herein are thickened compositions produced upon assembling a first sub-formulation having a hydroxide, and at least one second sub -formulation having an alkaline material, wherein at least one sub-formulation is thickened by lightly-to moderately-crosslinked PVP. Unlike other compositions not having the lightly-to moderately-crosslinked PVP, those described herein maintain or even build viscosity when the first and second sub -formulations are blended. The compositions may be utilized in the formulation of personal care and performance chemicals, such as hair relaxers, hair straighteners, depilators, degreasers, paint strippers, and cleaners. Methods for enhancing product handling and performance are also described. | 08-08-2013 |
Linda C. Giudice, Los Altos Hills, CA US
Patent application number | Description | Published |
---|---|---|
20080318237 | METHODS OF DIAGNOSING ENDOMETRIOSIS - The present invention provides biomarkers for the diagnosis and prognosis of endometriosis. Generally, the methods of this invention find use in diagnosing or for providing a prognosis for endometriosis by detecting the expression levels of biomarkers, which are differentially expressed (up- or down-regulated) in endometrial cells from a patient with endometriosis. Similarly, these markers can be used to diagnose reduced fertility in a patient with endometriosis or to provide a prognosis for a fertility trial in a patient suffering from endometriosis. The present invention also provides methods of identifying a compound for treating or preventing endometriosis. Finally, the present invention provides kits for the diagnosis or prognosis of endometriosis. | 12-25-2008 |
20110171631 | METHODS OF DIAGNOSING ENDOMETRIOSIS - The present invention provides biomarkers for the diagnosis and prognosis of endometriosis. Generally, the methods of this invention find use in diagnosing or for providing a prognosis for endometriosis by detecting the expression levels of biomarkers, which are differentially expressed (up- or down-regulated) in endometrial cells from a patient with endometriosis. Similarly, these markers can be used to diagnose reduced fertility in a patient with endometriosis or to provide a prognosis for a fertility trial in a patient suffering from endometriosis. The present invention also provides methods of identifying a compound for treating or preventing endometriosis. Finally, the present invention provides kits for the diagnosis or prognosis of endometriosis. | 07-14-2011 |
20130022593 | METHODS OF DIAGNOSING ENDOMETRIOSIS - The present invention provides biomarkers for the diagnosis and prognosis of endometriosis. Generally, the methods of this invention find use in diagnosing or for providing a prognosis for endometriosis by detecting the expression levels of biomarkers, which are differentially expressed (up- or down-regulated) in endometrial cells from a patient with endometriosis. Similarly, these markers can be used to diagnose reduced fertility in a patient with endometriosis or to provide a prognosis for a fertility trial in a patient suffering from endometriosis. The present invention also provides methods of identifying a compound for treating or preventing endometriosis. Finally, the present invention provides kits for the diagnosis or prognosis of endometriosis. | 01-24-2013 |
20140024557 | METHODS OF DIAGNOSING ENDOMETRIOSIS - The present invention provides biomarkers for the diagnosis and prognosis of endometriosis. Generally, the methods of this invention find use in diagnosing or for providing a prognosis for endometriosis by detecting the expression levels of biomarkers, which are differentially expressed (up- or down-regulated) in endometrial cells from a patient with endometriosis. Similarly, these markers can be used to diagnose reduced fertility in a patient with endometriosis or to provide a prognosis for a fertility trial in a patient suffering from endometriosis. The present invention also provides methods of identifying a compound for treating or preventing endometriosis. Finally, the present invention provides kits for the diagnosis or prognosis of endometriosis. | 01-23-2014 |
Linda C. Hsieh-Wilson, South Pasadena, CA US
Patent application number | Description | Published |
---|---|---|
20140323699 | METHOD OF DETECTING CANCER BASED ON GLYCAN BIOMARKERS - The present invention provides a method for labeling or detecting a protein with certain glycosyl groups. The methods are particularly useful for detecting cancer cells comprising the detected glycosyl groups. The present invention further provides labeling agents and detection agents, labeled proteins and mixtures, and kits and arrays thereof. | 10-30-2014 |
20150038436 | TAILORED GLYCOPOLYMERS AS ANTICOAGULANT HEPARIN MIMETICS - The present disclosure provides for methods and compositions comprising a series of synthetic glycopolymers. The disclosure also relates to a kit which is suitable for carrying out the inventive methods. | 02-05-2015 |
20150038455 | HEPARAN SULFATE/HEPARIN MIMETICS WITH ANTI-CHEMOKINE AND ANTI-INFLAMMATORY ACTIVITY - The present disclosure provides for methods and compositions comprising a series of synthetic glycopolymers. The disclosure also relates to a kit which is suitable for carrying out the inventive methods. | 02-05-2015 |
Linda C. Hsieh-Wilson, San Marino, CA US
Patent application number | Description | Published |
---|---|---|
20100075920 | SMALL MOLECULE STIMULATORS OF NEURONAL GROWTH - Provided herein are small molecule stimulators of neuronal growth, their preparation, and their use for treatment of neurological disorders. In one embodiment, provided herein are methods of treatment, prevention, or amelioration of a variety of medical conditions associated with neurological disorders using the compounds and compositions provided herein. | 03-25-2010 |
20110020359 | METHODS AND COMPOSITIONS FOR TREATING NEURONAL DAMAGE OR DEGENERATION - This invention provides methods and compositions for reducing chondroitin-sulfate-proteoglycan-mediated inhibition of neuronal growth. The methods and compositions provided herein are particularly useful for treatment of neuronal damage or degeneration. | 01-27-2011 |
Linda C. Meade-Tollin, Tucson, AZ US
Patent application number | Description | Published |
---|---|---|
20090016961 | Stem Cell Fusion Model of Carcinogenesis - Methods for modeling cancer cell migration, screening drugs for effects on tumor cell migration, and detecting the potential for tumor cell migration relating to the fusion of a bone marrow derived stem cell with a genetically altered cell (FIG. | 01-15-2009 |
20120201808 | Stem Cell Fusion Model of Carcinogenesis - Methods for modeling cancer cell migration, screening drugs for effects on tumor cell migration, and detecting the potential for tumor cell migration relating to the fusion of a bone marrow derived stem cell with a genetically altered cell. Antibodies against ubiquitin are shown to inhibit tumor cell migration. | 08-09-2012 |
20120295344 | Stem Cell Fusion Model of Carcinogenesis - Model systems and methods for exploring mechanisms of carcinogenesis and the acquisition of metastatic ability, and to provide insights into potential therapeutic targets. The systems include and methods involve fusion of a stem cell and a genetically altered cell to evaluate carcinogenesis and metastasis and for the discovery and evaluation of new therapeutic targets to inhibit metastasis and other markers of carcinogenesis. | 11-22-2012 |
20140308297 | Stem Cell Fusion Model of Carcinogenesis - Model systems and methods for exploring mechanisms of carcinogenesis and the acquisition of metastatic ability, and to provide insights into potential therapeutic targets. The systems include and methods involve fusion of a stem cell and a genetically altered cell to evaluate carcinogenesis and metastasis and for the discovery and evaluation of new therapeutic targets to inhibit metastasis and other markers of carcinogenesis. | 10-16-2014 |
Linda C. Uhlir-Tsang, Corvallis, OR US
Patent application number | Description | Published |
---|---|---|
20090087594 | Additives for use in print media to reduce bronzing - An additive used in a print medium to reduce bronzing. The additive increases a pH of the print medium. The additive is an organic base or an inorganic base. The additive reduces bronzing of an image printed with a dye-based inkjet ink. | 04-02-2009 |
20100112222 | DYE-BASED INK - A dye-based ink includes a dye and a solvent. The dye-based ink has a high print quality on plain paper. The dye-based ink may have a print quality similar to pigment-based inks. This may be particularly relevant for black inks. | 05-06-2010 |
20100251933 | Magenta Inks And Ink Sets For Ink-jet Imaging - The present invention is directed to magenta inks and ink sets for ink-jet printing. The inks and ink sets provide exceptional ozone fastness, particularly when printed on porous media or plain paper. The inks of the ink sets are formulated to be compatible with each other and are capable of producing high quality printed images. | 10-07-2010 |
Linda C. Van Guilder, Oakton, VA US
Patent application number | Description | Published |
---|---|---|
20110040552 | Structured data translation apparatus, system and method - An apparatus is provided that includes a processor and a memory. The processor is configured to determine a category for a group of isolated noun phrases in a structured or semi-structured data source stored in the memory. The group of isolated noun phrases includes one or more isolated noun phrases. The processor is also configured to translate the group of isolated noun phrases from a source language to a target language using a category-driven isolated noun phrase translation. The determination of the category and the category-driven isolated noun phrase translation are performed based on context derived from the group of isolated noun phrases. | 02-17-2011 |
Linda C. Veren, Sudbury, MA US
Patent application number | Description | Published |
---|---|---|
20140129256 | SYSTEM AND METHOD FOR IDENTIFYING HEALTHCARE FRAUD - In general, one aspect of the subject matter described herein can be embodied in methods that include the actions of: identifying one or more claims associated with a patient, selecting, from the identified claims at least a first claim and a second claim, comparing one or more patient claim parameters of the first claim with one or more patient claim parameters of the second claim, determining, based on the comparing, one or more patient variables, the one or more patient variables reflecting one or more aspects of the one or more claims associated with the patient, processing the respective determined patient variables to identify one or more patient clusters, each of the one or more patient clusters including one or more claims having one or more substantially similar patient variables, and, providing, based on the one or more identified patient clusters, notifications with respect to a medical entity record. | 05-08-2014 |